InvestorsHub Logo
Followers 145
Posts 27558
Boards Moderated 3
Alias Born 02/07/2004

Re: midastouch017 post# 1779

Saturday, 12/16/2017 10:52:25 AM

Saturday, December 16, 2017 10:52:25 AM

Post# of 1834
Treatment for Alzheimer’s, Parkinson’s gets a boost. There’s a Miami connection.
BY JANE WOOLDRIDGE
jwooldridge@miamiherald.com

DECEMBER 15, 2017 12:24 PM

UPDATED DECEMBER 15, 2017 03:43 PM

Potential new treatments for Alzheimer’s and Parkinson’s patients just got a boost.

INSIGHTEC, a medical device company led by Miami’s Dr. Maurice Ferre, has received $150 million in funding from Koch Disruptive Technologies, a subsidiary of Koch Industries.

The money will enable INSIGHTEC to expand studies of its current FDA-cleared ultrasound device to Alzheimer’s and Parkinson’s patients. The company currently is conducting a Phase 1 trial into Alzheimer’s treataments and beginning at Phase 3 trial in uses for Parkinson’s Disease.

The non-invasive device uses Magnetic Resonance Imaging and focused ultrasound to target specific tissues in a procedure called Exablate Neuro. It is now used for uncontrollable tremors, called essential tremor, at 40 medical centers worldwide, including two in South Florida. The underlying technology can also be used to treat uterine fibroids and bone cancer non-invasively.

INSIGHTEC is based in Israel, with U.S. offices in Miami. Ferre, a serial entrepreneur, co-founded MAKO Surgical Corp., a leader in robotic orthopedic surgery. His father, Maurice Ferre, was a long-time mayor of Miami.